Intravenous Infusions Plc (GHSE:IIL)
Ghana · Delayed Price · Currency is GHS 0.0500
0.00 (0.00%)
At close: Sep 11, 2025
Intravenous Infusions Income Statement
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 19.4 | 24.94 | 31.42 | 20.36 | 22.67 | 20.67 | Upgrade | |
Revenue Growth (YoY) | -36.32% | -20.61% | 54.34% | -10.21% | 9.69% | -10.47% | Upgrade |
Cost of Revenue | 12.6 | 13.39 | 14.14 | 11.6 | 12.04 | 10.49 | Upgrade |
Gross Profit | 6.8 | 11.55 | 17.28 | 8.76 | 10.63 | 10.18 | Upgrade |
Selling, General & Admin | 8.42 | 10.07 | 9.96 | 11.39 | 8.86 | 7.81 | Upgrade |
Operating Expenses | 9.08 | 10.73 | 10.76 | 11.96 | 9.41 | 8.52 | Upgrade |
Operating Income | -2.28 | 0.82 | 6.52 | -3.21 | 1.23 | 1.66 | Upgrade |
Interest Expense | - | -0.14 | -0.72 | -0.39 | -0.15 | -0.33 | Upgrade |
Other Non Operating Income (Expenses) | 0.96 | -1.17 | -2.35 | 0.06 | 0.36 | 0.03 | Upgrade |
EBT Excluding Unusual Items | -1.14 | -0.49 | 3.44 | -3.54 | 1.43 | 1.36 | Upgrade |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 0.05 | 0 | - | - | Upgrade |
Pretax Income | -1.13 | -0.49 | 3.49 | -3.53 | 1.43 | 1.36 | Upgrade |
Income Tax Expense | 0.04 | 0.16 | 0.95 | -0.02 | 0.29 | -0.09 | Upgrade |
Net Income | -1.17 | -0.64 | 2.54 | -3.51 | 1.15 | 1.45 | Upgrade |
Net Income to Common | -1.17 | -0.64 | 2.54 | -3.51 | 1.15 | 1.45 | Upgrade |
Net Income Growth | - | - | - | - | -20.99% | -22.44% | Upgrade |
Shares Outstanding (Basic) | 268 | 274 | 274 | 274 | 274 | 274 | Upgrade |
Shares Outstanding (Diluted) | 268 | 274 | 274 | 274 | 274 | 274 | Upgrade |
Shares Change (YoY) | -2.87% | - | - | - | - | 7.09% | Upgrade |
EPS (Basic) | -0.00 | -0.00 | 0.01 | -0.01 | 0.00 | 0.01 | Upgrade |
EPS (Diluted) | -0.00 | -0.00 | 0.01 | -0.01 | 0.00 | 0.01 | Upgrade |
EPS Growth | - | - | - | - | -21.00% | -27.57% | Upgrade |
Free Cash Flow | 4.46 | 6.26 | 2.39 | 0.45 | -3.86 | -4.46 | Upgrade |
Free Cash Flow Per Share | 0.02 | 0.02 | 0.01 | 0.00 | -0.01 | -0.02 | Upgrade |
Dividend Per Share | - | - | 0.004 | - | - | 0.003 | Upgrade |
Dividend Growth | - | - | - | - | - | -33.86% | Upgrade |
Gross Margin | 35.04% | 46.31% | 55.01% | 43.02% | 46.91% | 49.27% | Upgrade |
Operating Margin | -11.76% | 3.28% | 20.74% | -15.76% | 5.42% | 8.03% | Upgrade |
Profit Margin | -6.05% | -2.58% | 8.10% | -17.24% | 5.06% | 7.02% | Upgrade |
Free Cash Flow Margin | 22.98% | 25.09% | 7.59% | 2.22% | -17.03% | -21.58% | Upgrade |
EBITDA | -1.72 | 1.47 | 7.31 | -2.64 | 1.76 | 2.36 | Upgrade |
EBITDA Margin | -8.86% | 5.89% | 23.27% | -12.98% | 7.79% | 11.41% | Upgrade |
D&A For EBITDA | 0.56 | 0.65 | 0.79 | 0.56 | 0.54 | 0.7 | Upgrade |
EBIT | -2.28 | 0.82 | 6.52 | -3.21 | 1.23 | 1.66 | Upgrade |
EBIT Margin | -11.76% | 3.28% | 20.74% | -15.76% | 5.42% | 8.03% | Upgrade |
Effective Tax Rate | - | - | 27.17% | - | 19.97% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.